Kumar Ashok, Narang Jagriti, Mohan Hari
Centre for Medical Biotechnology, Maharshi Dayanand University, Rohtak, Haryana, 124001, India.
CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi, 110007, India.
Sens Int. 2022;3:100197. doi: 10.1016/j.sintl.2022.100197. Epub 2022 Jul 30.
Covid-19 is a dreadful pandemic of the 21st century that has created fear among people, affected the whole world, and taken thousands of lives. It infects the respiratory system and causes flu-type symptoms. According to the WHO reports, 2,082,745 deaths and 96,267,473 confirmed cases were perceived all around the globe till January 22, 2021. The significant roots of transmission are inhalation and direct contact with the infected surface. Its incubation period is 2-14 days and remains asymptomatic in most people. However, no treatment and vaccine are available for the people, so preventive measures like social distancing, wearing personal protective equipment (PPE), and frequent hand-washing are the practical and only options for cure. It has affected every sector of the world, whether it is trade or health all around the world. There is high demand for diagnostic tools as high-scale and expeditious testing is crucial for controlling disease spread; thus, detection methods play an essential role. Like flu, Covid-19 is also detected through RT-PCR, as the World Health Organization (WHO) suggested, but it is time taking and expensive method that many countries cannot afford. A vaccine is a crucial aspect of eradicating disease, and for SARS-CoV-2), plasma therapy and antibiotics therapy are used in the early spreading phase. The later stage involves forming a vaccine based on spike protein, N-protein, and whole-viral antigen that effectively immunizes the population worldwide until herd immunity can be achieved. In this review, we will discuss all possible and developed techniques for identifying SARS-CoV-2 and make a comparison of their specificity, selectivity, and cost; thus, we choose an appropriate method for fast, reliable, and pocket-friendly detection.
新冠疫情是21世纪一场可怕的大流行病,它在人们中间引发了恐惧,影响了整个世界,并夺走了数千人的生命。它感染呼吸系统并引发流感样症状。根据世界卫生组织的报告,截至2021年1月22日,全球共出现2082745例死亡病例和96267473例确诊病例。主要传播途径是吸入和直接接触受感染的表面。其潜伏期为2至14天,大多数人感染后无症状。然而,目前尚无针对该疾病的治疗方法和疫苗,因此,诸如保持社交距离、佩戴个人防护装备(PPE)和勤洗手等预防措施是切实可行且唯一的治疗选择。它影响了世界的各个领域,无论是全球的贸易还是卫生领域。对诊断工具的需求很高,因为大规模和快速检测对于控制疾病传播至关重要;因此,检测方法起着至关重要的作用。与流感一样,世界卫生组织(WHO)建议通过逆转录聚合酶链反应(RT-PCR)检测新冠病毒,但这是一种耗时且昂贵的方法,许多国家无法承受。疫苗是根除疾病的关键因素,对于严重急性呼吸综合征冠状病毒2(SARS-CoV-2),在疫情早期传播阶段采用了血浆疗法和抗生素疗法。后期则涉及基于刺突蛋白、核蛋白和全病毒抗原研发疫苗,以有效免疫全球人群,直至实现群体免疫。在本综述中,我们将讨论所有可能的和已开发的用于识别SARS-CoV-2的技术,并比较它们的特异性、选择性和成本;从而选择一种快速、可靠且经济实惠的检测方法。